CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $110,208 | -69.5% | 67,200 | -4.4% | 0.00% | – |
| Q1 2024 | $361,146 | -18.2% | 70,262 | -8.8% | 0.00% | – |
| Q4 2023 | $441,376 | +35.1% | 77,029 | +12.7% | 0.00% | – |
| Q3 2023 | $326,780 | +16.6% | 68,364 | +3.7% | 0.00% | – |
| Q2 2023 | $280,271 | -24.0% | 65,946 | -5.1% | 0.00% | – |
| Q1 2023 | $368,849 | +172.7% | 69,463 | +222.5% | 0.00% | – |
| Q4 2022 | $135,277 | -95.9% | 21,541 | -93.2% | 0.00% | -100.0% |
| Q3 2022 | $3,324,000 | +3224.0% | 315,052 | +1611.4% | 0.00% | – |
| Q2 2022 | $100,000 | -9.1% | 18,409 | +52.0% | 0.00% | – |
| Q1 2022 | $110,000 | – | 12,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
| Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
| 72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
| PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
| Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
| Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
| Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
| Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
| Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |